Testing effectiveness (Phase 2)Study completedNCT01244906
What this trial is testing
Post-transplant Cyclophosphamide and Sirolimus Following Reduced Intensity Conditioning (RIC) Transplant
Who this might be right for
Hematologic Neoplasms
Northside Hospital, Inc. 26